EUVIMEDEUVIMED entdecken
Crossref

Hybrid Nanoparticles of Extracellular Vesicles and Gemcitabine Prodrug-Loaded Liposomes with Enhanced Targeting Ability for Effective PDAC Treatment

Bora Kim, Heewon Park, Haoyan Liu, Sejin Kim, Yong-Kyu Lee, Yeu-Chun Kim iD

ACS Applied Bio Materials · 16.09.2024 · 7 (9) · 6025-6033

DOI: 10.1021/acsabm.4c00658 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 04.09.2024. Verfasst von Bora Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 305-701, Republic of Korea. Hauptthemen laut MEDLINE: Gemcitabine, Deoxycytidine, Prodrugs, Liposomes. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GemcitabineDeoxycytidineProdrugsLiposomesNanoparticlesPancreatic NeoplasmsExtracellular VesiclesParticle SizeCarcinoma, Pancreatic DuctalDrug Screening Assays, AntitumorHumansBiocompatible MaterialsCell ProliferationMaterials TestingCell Line, TumorCell SurvivalDrug Delivery SystemsAntineoplastic Agents

Stichwörter der Autor:innen

PDACexosomegemcitabine prodrughybrid nanoparticleliposometarget drug delivery

Substanzen

GemcitabineDeoxycytidineProdrugsLiposomesBiocompatible MaterialsAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 305-701, Republic of Korea.
  • Department of Chemical and Biological Engineering, Korea National University of Transportation, Chungju, Chung-Buk 27469, Republic of Korea.
  • 4D Convergence Technology Institute (National Key Technology Institute in University), Korea National University of Transportation, Jeungpyeong 27909, Republic of Korea.

ORCID-Profile: Yeu-Chun Kim

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Kim, B., Park, H., Liu, H., Kim, S., Lee, Y. K., & Kim, Y. C. (2024). Hybrid Nanoparticles of Extracellular Vesicles and Gemcitabine Prodrug-Loaded Liposomes with Enhanced Targeting Ability for Effective PDAC Treatment. ACS Applied Bio Materials, 7(9), 6025-6033. https://doi.org/10.1021/acsabm.4c00658

Vancouver

Kim B, Park H, Liu H, Kim S, Lee YK, Kim YC. Hybrid Nanoparticles of Extracellular Vesicles and Gemcitabine Prodrug-Loaded Liposomes with Enhanced Targeting Ability for Effective PDAC Treatment. ACS Applied Bio Materials. 2024;7(9):6025-6033. doi:10.1021/acsabm.4c00658

BibTeX
@article{Kim2024,
  author = {Kim, Bora and Park, Heewon and Liu, Haoyan and Kim, Sejin and Lee, Yong-Kyu and Kim, Yeu-Chun},
  title = {Hybrid Nanoparticles of Extracellular Vesicles and Gemcitabine Prodrug-Loaded Liposomes with Enhanced Targeting Ability for Effective PDAC Treatment},
  journal = {ACS Applied Bio Materials},
  year = {2024},
  volume = {7},
  number = {9},
  pages = {6025--6033},
  doi = {10.1021/acsabm.4c00658}
}
Kostenlos starten →